Radiopharmaceuticals Market Is Projected to Soar Steadily at 5.9% CAGR During 2016-2026
Presence of radiopharmaceuticals in cancer medications has increased as research institutes have derived ways in which radioisotopes can impede the maturation of malignant tumour, cells and tissues.
View full press release